Inheritance of von Willebrand disease Vicenza in a Japanese family
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - March 26, 2018 Category: Hematology Source Type: research
Successful treatment of acquired von Willebrand disease with lenalidomide leading to dramatic resolution of intractable gastrointestinal bleeding: A case report
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - March 26, 2018 Category: Hematology Source Type: research
Desmopressin stimulation testing: Response to intravenous and intranasal forms
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - March 26, 2018 Category: Hematology Source Type: research
Moderate and severe haemophilia in Spain: An epidemiological update
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - March 26, 2018 Category: Hematology Source Type: research
Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - March 25, 2018 Category: Hematology Source Type: research
Arteriovenous shunts as venous access in children with haemophilia
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - March 24, 2018 Category: Hematology Source Type: research
Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen ‐Bethesda assay for factor VIII inhibitors
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - March 24, 2018 Category: Hematology Source Type: research
Analysis of current perioperative management with Haemate ® P/Humate P® in von Willebrand disease: Identifying the need for personalized treatment
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - March 24, 2018 Category: Hematology Source Type: research
Immune tolerance induction: What have we learned over time?
Haemophilia,Volume 24, Issue S3, Page 3-14, April 2018. (Source: Haemophilia)
Source: Haemophilia - March 15, 2018 Category: Hematology Source Type: research
Issue Information
Haemophilia,Volume 24, Issue S3, Page 1-2, April 2018. (Source: Haemophilia)
Source: Haemophilia - March 15, 2018 Category: Hematology Source Type: research
---
Haemophilia,Volume 24, Issue S3, Page 3-14, April 2018. (Source: Haemophilia)
Source: Haemophilia - March 15, 2018 Category: Hematology Source Type: research
---
Haemophilia,Volume 24, Issue S3, Page 1-2, April 2018. (Source: Haemophilia)
Source: Haemophilia - March 15, 2018 Category: Hematology Source Type: research
Immune tolerance induction: What have we learned over time?
Development of inhibitory antibodies to infused factor VIII (FVIII) concentrates continues to be the most serious complication of haemophilia A management. Induction of immune tolerance by administering high doses of FVIII concentrate (antigen) and prothrombin complex concentrates to control bleeding was originated in the 1970s in Bonn, Germany, by Dr Hans‐Hermann Brackmann, and became known as the Bonn protocol. ITI transformed the life of the index patient, who was 19 years of age when he began treatment, and dramatically improved the medical landscape for all patients with haemophilia and inhibitors. Over the past 40...
Source: Haemophilia - March 15, 2018 Category: Hematology Authors: H. ‐H. Brackmann, G.C. White, E. Berntorp, T. Andersen, C. Escuriola‐Ettingshausen Tags: REVIEW ARTICLE Source Type: research
Issue Information
(Source: Haemophilia)
Source: Haemophilia - March 15, 2018 Category: Hematology Tags: ISSUE INFORMATION Source Type: research
In vitro characterization of MOD ‐5014, a novel long‐acting carboxy‐terminal peptide (CTP)‐modified activated FVII
Haemophilia,Volume 24, Issue 3, Page 477-486, May 2018. (Source: Haemophilia)
Source: Haemophilia - March 14, 2018 Category: Hematology Authors: A.
Bar ‐Ilan
,
T.
Livnat
,
M.
Hoffmann
,
L.
Binder
,
M.
Zakar
,
R.
Guy
,
Y.
Felikman
,
L.
Moschcovich
,
B.
Shenkman
,
D.
Monroe
,
O.
Hershkovitz
,
G.
Kenet
,
G.
Hart Source Type: research
